Past decades of glioma research demonstrated a central role of p53 in the regulatory network of gliomagenesis and that the p53 status is closely associated with the disease progression and survival of patients with GBM during radio- and chemotherapy [89,90]. This evidence concerns the gene TP53 and glioma.